Postsynaptic density-membrane associated guanylate kinase proteins (PSD-MAGUKs) and their role in CNS disorders

Neuroscience

Volumn 158, Issue 1, 2009, Pages 324-333

  Gardoni, F ^a   Marcello, E ^a   Di Luca, M ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

glutamate receptors; neurodegenerative disorders; phosphorylation; postsynaptic density; trafficking

Indexed keywords

CASEIN KINASE II; GLUTAMATE RECEPTOR 2; GLUTAMIC ACID; IONOTROPIC RECEPTOR; MEMBRANE ASSOCIATED GUANYLATE CYCLASE KINASE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2A; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; POSTSYNAPTIC DENSITY PROTEIN 95; RECEPTOR SUBUNIT;

ALZHEIMER DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; EXCITOTOXICITY; HUMAN; LONG TERM POTENTIATION; NERVE CELL PLASTICITY; NEUROPATHIC PAIN; NONHUMAN; PARKINSON DISEASE; PATHOPHYSIOLOGY; POSTSYNAPTIC MEMBRANE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION;

ANIMALS; BRAIN; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE PROTEINS; NEURODEGENERATIVE DISEASES; RECEPTORS, GLUTAMATE; SYNAPSES; SYNAPTIC MEMBRANES; SYNAPTIC TRANSMISSION;

EID: 58149469930     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2008.07.068     Document Type: Review

References (81)

1. Aarts M., Liu Y., Liu L., Besshoh S., Arundine M., Gurd J.W., Wang Y.T., Salter M.W., and Tymianski M. Treatment of ischemic brain damage by perturbing NMDA receptor-PSD-95 protein interactions. Science 298 (2002) 846-850
2. Almeida C.G., Tampellini D., Takahashi R.H., Greengard P., Lin M.T., Snyder E.M., and Gouras G.K. Beta-amyloid accumulation in APP mutant neurons reduces PSD-95 and GluR1 in synapses. Neurobiol Dis 20 (2005) 187-198
3. Aoki C., Miko I., Oviedo H., Mikeladze-Dvali T., Alexandre L., Sweeney N., and Bredt D.S. Electron microscopic immunocytochemical detection of PSD-95, PSD-93, SAP-102, and SAP-97 at postsynaptic, presynaptic, and nonsynaptic sites of adult and neonatal rat visual cortex. Synapse 40 (2001) 239-257
4. Bertoni-Freddari C., Fattoretti P., Casoli T., Caselli U., and Meier-Ruge W. Deterioration threshold of synaptic morphology in aging and senile dementia of Alzheimer's type. Anal Quant Cytol Histol 18 (1996) 209-213
5. Calabresi P., Pisani A., Mercuri N.B., and Bernardi G. The corticostriatal projection: from synaptic plasticity to dysfunctions of the basal ganglia. Trends Neurosci 19 (1996) 19-24
6. Calabresi P., Centonze D., and Bernardi G. Electrophysiology of dopamine in normal and denervated striatal neurons. Trends Neurosci 23 (2000) S57-S63
7. Chen H.J., Rojas-Soto M., Oguni A., and Kennedy M.B. A synaptic Ras-GTPase activating protein (p135 SynGAP) inhibited by CaM kinase II. Neuron 20 (1998) 895-904
8. Christopherson K.S., Hillier B.J., Lim W.A., and Bredt D.S. PSD-95 assembles a ternary complex with the N-methyl-D-aspartic acid receptor and a bivalent neuronal NO synthase PDZ domain. J Biol Chem 274 (1999) 27467-27473
9. Chung H.J., Huang Y.H., Lau L.F., and Huganir R.L. Regulation of the NMDA receptor complex and trafficking by activity-dependent phosphorylation of the NR2B subunit PDZ ligand. J Neurosci 24 (2004) 10248-10259
10. Coleman P.D., and Yao P.J. Synaptic slaughter in Alzheimer's disease. Neurobiol Aging 24 (2003) 1023-1027
11. Collingridge G.L., Isaac J.T., and Wang Y.T. Receptor trafficking and synaptic plasticity. Nat Rev Neurosci 5 (2004) 952-962
12. Conroy W.G., Liu Z., Nai Q., Coggan J.S., and Berg D.K. PDZ-containing proteins provide a functional postsynaptic scaffold for nicotinic receptors in neurons. Neuron 38 (2003) 759-771
13. DeKosky S.T., and Scheff S.W. Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity. Ann Neurol 27 (1990) 457-464
14. Dewachter I., Filipkowski R.K., Priller C., Ris L., Neyton J., Croes S., Terwel D., Gysemans M., Devijver H., Borghgraef P., Godaux E., Kaczmarek L., Herms J., and Van Leuven F. Deregulation of NMDA-receptor function and down-stream signaling in APP[V717I] transgenic mice. Neurobiol Aging (2007). http://www.sciencedirect.com 2007: Jul 26; [Epub ahead of print]. http://www.sciencedirect.com. doi:1016/j.neurobiolaging.2007.06.011
15. Dudek S.M., and Bear M.F. Homosynaptic long-term depression in area CA1 of hippocampus and effects of N-methyl-D-aspartate receptor blockade. Proc Natl Acad Sci U S A 89 (1992) 4363-4367
16. Dunah A.W., Wang Y., Yasuda R.P., Kameyama K., Huganir R.L., Wolfe B.B., and Standaert D.G. Alterations in subunit expression, composition, and phosphorylation of striatal N-methyl-D-aspartate glutamate receptors in a rat 6-hydroxydopamine model of Parkinson's disease. Mol Pharmacol 57 (2000) 342-352
17. Dunah A.W., and Standaert D.G. Dopamine D1 receptor-dependent trafficking of striatal NMDA glutamate receptors to the postsynaptic membrane. J Neurosci 21 (2001) 5546-5558
18. Ehrlich I., and Malinow R. Postsynaptic density 95 controls AMPA receptor incorporation during long-term potentiation and experience-driven synaptic plasticity. J Neurosci 24 (2004) 916-927
19. El-Husseini A.E., Topinka J.R., Lehrer-Graiwer J.E., Firestein B.L., Craven S.E., Aoki C., and Bredt D.S. Ion channel clustering by membrane-associated guanylate kinases. Differential regulation by N-terminal lipid and metal binding motifs. J Biol Chem 275 (2000) 23904-23910
20. Elias G.M., and Nicoll R.A. Synaptic trafficking of glutamate receptors by MAGUK scaffolding proteins. Trends Cell Biol 17 (2007) 343-352
21. Garcia E.P., Mehta S., Blair L.A., Wells D.G., Shang J., Fukushima T., Fallon J.R., Garner C.C., and Marshall J. SAP90 binds and clusters kainate receptors causing incomplete desensitization. Neuron 21 (1998) 727-739
22. Gardoni F., Mauceri D., Fiorentini C., Bellone C., Missale C., Cattabeni F., and Di Luca M. CaMKII-dependent phosphorylation regulates SAP97/NR2A interaction. J Biol Chem 278 (2003) 44745-44752
23. Gardoni F., Picconi B., Ghiglieri V., Polli F., Bagetta V., Bernardi G., Cattabeni F., Di Luca M., and Calabresi P. A critical interaction between NR2B and MAGUK in L-DOPA induced dyskinesia. J Neurosci 26 (2006) 2914-2922
24. Gardoni F., Polli F., Cattabeni F., and Di Luca M. Calcium-calmodulin-dependent protein kinase II phosphorylation modulates PSD-95 binding to NMDA receptors. Eur J Neurosci 24 (2006) 2694-2704
25. Garner C.C., Nash J., and Huganir R.L. PDZ domains in synapse assembly and signalling. Trends Cell Biol 10 (2000) 274-280
26. Garry E.M., Moss A., Delaney A., O'Neill F., Blakemore J., Bowen J., Husi H., Mitchell R., Grant S.G., and Fleetwood-Walker S.M. Neuropathic sensitization of behavioral reflexes and spinal NMDA receptor/CaM kinase II interactions are disrupted in PSD-95 mutant mice. Curr Biol 13 (2003) 321-328
27. Gylys K.H., Fein J.A., Yang F., Wiley D.J., Miller C.A., and Cole G.M. Synaptic changes in Alzheimer's disease: increased amyloid-beta and gliosis in surviving terminals is accompanied by decreased PSD-95 fluorescence. Am J Pathol 165 (2004) 1809-1817
28. Hynd M.R., Scott H.L., and Dodd P.R. Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer's disease. Neurochem Int 45 (2004) 583-595
29. Ingham C.A., Hood S.H., Taggart P., and Arbuthnott G.W. Plasticity of synapses in the rat neostriatum after unilateral lesion of the nigrostriatal dopaminergic pathway. J Neurosci 18 (1998) 4732-4743
30. Irie M., Hata Y., Takeuchi M., Ichtchenko K., Toyoda A., Hirao K., Takai Y., Rosahl T.W., and Sudhof T.C. Binding of neuroligins to PSD-95. Science 277 (1997) 1511-1515
31. Kalia L.V., and Salter M.W. Interactions between Src family protein tyrosine kinases and PSD-95. Neuropharmacology 45 (2003) 720-728
32. Kalia L.V., Pitcher G.M., Pelkey K.A., and Salter M.W. PSD-95 is a negative regulator of the tyrosine kinase Src in the NMDA receptor complex. EMBO J 25 (2006) 4971-4982
33. Kemp J.A., and McKernan R.M. NMDA receptor pathways as drug targets. Nat Neurosci 5 (2002) 1039-1042
34. Kennedy M.B. Signal-processing machines at the postsynaptic density. Science 290 (2000) 750-754
35. + channels by interaction with a family of membrane-associated guanylate kinases. Nature 378 (1995) 85-88
36. Kim J.H., Liao D., Lau L.F., and Huganir R.L. SynGAP: a synaptic RasGAP that associates with the PSD-95/SAP90 protein family. Neuron 20 (1998) 683-691
37. Kim E., and Sheng M. PDZ domain proteins of synapses. Nat Rev Neurosci 5 (2004) 771-781
38. Kim M.J., Futai K., Jo J., Hayashi Y., Cho K., and Sheng M. Synaptic accumulation of PSD-95 and synaptic function regulated by phosphorylation of serine-295 of PSD-95. Neuron 56 (2007) 488-502
39. Kornau H.C., Schenker L.T., Kennedy M.B., and Seeburg P.H. Domain interaction between NMDA receptor subunits and the postsynaptic density protein PSD-95. Science 269 (1995) 1737-1740
40. Lacor P.N., Buniel M.C., Chang L., Fernandez S.J., Gong Y., Viola K.L., Lambert M.P., Velasco P.T., Bigio E.H., Finch C.E., Krafft G.A., and Klein W.L. Synaptic targeting by Alzheimer's-related amyloid beta oligomers. J Neurosci 24 (2004) 10191-10200
41. Lau C.G., and Zukin R.S. NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders. Nat Rev Neurosci 8 (2007) 413-426
42. Leonard A.S., Davare M.A., Horne M.C., Garner C.C., and Hell J.W. SAP97 is associated with the alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor GluR1 subunit. J Biol Chem 273 (1998) 19518-19524
43. Lin Y., Jover-Mengual T., Wong J., Bennett M.V., and Zukin R.S. PSD-95 and PKC converge in regulating NMDA receptor trafficking and gating. Proc Natl Acad Sci U S A 103 (2006) 19902-19907
44. Lipton S.A. The molecular basis of memantine action in Alzheimer's disease and other neurologic disorders: low-affinity, uncompetitive antagonism. Curr Alzheimer Res 2 (2005) 155-165
45. Lynch D.R., and Guttmann R.P. Excitotoxicity: perspectives based on N-methyl-D-aspartate receptor subtypes. J Pharmacol Exp Ther 300 (2002) 717-723
46. Marcello E., Gardoni F., Mauceri D., Romorini S., Jeromin A., Epis R., Borroni B., Cattabeni F., Sala C., Padovani A., and Di Luca M. Synapse-associated protein-97 mediates alpha-secretase ADAM10 trafficking and promotes its activity. J Neurosci 27 (2007) 1682-1691
47. Mauceri D., Cattabeni F., Di Luca M., and Gardoni F. Calcium/calmodulin-dependent protein kinase II phosphorylation drives synapse-associated protein 97 into spines. J Biol Chem 279 (2004) 23813-23821
48. Mauceri D., Gardoni F., Marcello E., and Di Luca M. Dual role of CaMKII-dependent SAP97 phosphorylation in mediating trafficking and insertion of NMDA receptor subunit NR2A. J Neurochem 100 (2007) 1032-1046
49. Menegoz M., Lau L.F., Herve D., Huganir R.L., and Girault J.A. Tyrosine phosphorylation of NMDA receptor in rat striatum: effects of 6-OHdopamine lesions. Neuroreport 7 (1995) 125-128
50. Miguel-Hidalgo J.J., Alvarez X.A., Cacabelos R., and Quack G. Neuroprotection by memantine against neurodegeneration induced by beta-amyloid(1-40). Brain Res 958 (2002) 210-221
51. Mishizen-Eberz A.J., Rissman R.A., Carter T.L., Ikonomovic M.D., Wolfe B.B., and Armstrong D.M. Biochemical and molecular studies of NMDA receptor subunits NR1/2A/2B in hippocampal subregions throughout progression of Alzheimer's disease pathology. Neurobiol Dis 15 (2004) 80-92
52. Morabito M.A., Sheng M., and Tsai L.H. Cyclin-dependent kinase 5 phosphorylates the N-terminal domain of the postsynaptic density protein PSD-95 in neurons. J Neurosci 24 (2004) 865-876
53. Muller B.M., Kistner U., Kindler S., Chung W.J., Kuhlendahl S., Fenster S.D., Lau L.F., Veh R.W., Huganir R.L., Gundelfinger E.D., and Garner C.C. SAP102, a novel postsynaptic protein that interacts with NMDA receptor complexes in vivo. Neuron 17 (1996) 255-265
54. Nash J.E., Johnston G.L., Collingridge G.L., Garner C.C., and Brotchie J.M. Subcellular redistribution of the synapse-associated proteins PSD-95 and SAP97 in animal models of Parkinson's disease and L-DOPA-induced dyskinesia. FASEB J 19 (2005) 583-585
55. Niethammer M., Kim E., and Sheng M. Interaction between the C terminus of NMDA receptor subunits and multiple members of the PSD-95 family of membrane-associated guanylate kinases. J Neurosci 16 (1996) 2157-2163
56. Oddo S., Caccamo A., Shepherd J.D., Murphy M.P., Golde T.E., Kayed R., Metherate R., Mattson M.P., Akbari Y., and LaFerla F.M. Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 39 (2003) 409-421
57. Palop J.J., Jones B., Kekonius L., Chin J., Yu G.Q., Raber J., Masliah E., and Mucke L. Neuronal depletion of calcium-dependent proteins in the dentate gyrus is tightly linked to Alzheimer's disease-related cognitive deficits. Proc Natl Acad Sci U S A 100 (2003) 9572-9577
58. Papa S.M., and Chase T.N. Levodopa-induced dyskinesias improved by a glutamate antagonist in parkinsonian monkeys. Ann Neurol 39 (1996) 574-578
59. Parsons C.G., Danysz W., and Quack G. Memantine is a clinically well tolerated N-methyl- D-aspartate (NMDA) receptor antagonist: a review of preclinical data. Neuropharmacology 38 (1999) 735-767
60. Picconi B., Centonze D., Hakansson K., Bernardi G., Greengard P., Fisone G., Cenci M.A., and Calabresi P. Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia. Nat Neurosci 6 (2003) 501-506
61. 2+-calmodulin-dependent protein kinase II function mediates synaptic and motor deficits in experimental parkinsonism. J Neurosci 24 (2004) 5283-5291
62. Prybylowski K., Chang K., Sans N., Kan L., Vicini S., and Wenthold R.J. The synaptic localization of NR2B-containing NMDA receptors is controlled by interactions with PDZ proteins and AP-2. Neuron 47 (2005) 845-857
63. Rumbaugh G., Sia G.M., Garner C.C., and Huganir R.L. Synapse-associated protein-97 isoform-specific regulation of surface AMPA receptors and synaptic function in cultured neurons. J Neurosci 23 (2003) 4567-4576
64. Sans N., Prybylowski K., Petralia R.S., Chang K., Wang Y.X., Racca C., Vicini S., and Wenthold R.J. NMDA receptor trafficking through an interaction between PDZ proteins and the exocyst complex. Nat Cell Biol 5 (2003) 520-530
65. Sattler R., and Tymianski M. Molecular mechanisms of glutamate receptor mediated excitotoxic neuronal cell death. Mol Neurobiol 24 (2001) 107-129
66. Scarpini E., Scheltens P., and Feldman H. Treatment of Alzheimer's disease: current status and new perspectives. Lancet Neurol 2 (2003) 539-547
67. Schnell E., Sizemore M., Karimzadegan S., Chen L., Bredt D.S., and Nicoll R.A. Direct interactions between PSD-95 and stargazin control synaptic AMPA receptor number. Proc Natl Acad Sci U S A 99 (2002) 13902-13907
68. Selkoe D.J. Alzheimer's disease is a synaptic failure. Science 298 (2002) 789-791
69. Snyder E.M., Nong Y., Almeida C.G., Paul S., Moran T., Choi E.Y., Nairn A.C., Salter M.W., Lombroso P.J., Gouras G.K., and Greengard P. Regulation of NMDA receptor trafficking by amyloid-beta. Nat Neurosci 8 (2005) 1051-1058
70. Stein V., House D.R., Bredt D.S., and Nicoll R.A. Postsynaptic density-95 mimics and occludes hippocampal long-term potentiation and enhances long-term depression. J Neurosci 23 (2003) 5503-5506
71. Takagi N., Cheung H.H., Bissoon N., Teves L., Wallace M.C., and Gurd J.W. The effect of transient global ischemia on the interaction of Src and Fyn with the N-methyl-D-aspartate receptor and postsynaptic densities: possible involvement of Src homology 2 domains. J Cereb Blood Flow Metab 19 (1999) 880-888
72. Tao Y.X., Rumbaugh G., Wang G.D., Petralia R.S., Zhao C., Kauer F.W., Tao F., Zhuo M., Wenthold R.J., Raja S.N., Huganir R.L., Bredt D.S., and Johns R.A. Impaired NMDA receptor-mediated postsynaptic function and blunted NMDA receptor-dependent persistent pain in mice lacking postsynaptic density-93 protein. J Neurosci 23 (2003) 6703-6712
73. Tao Y.X., and Raja S.N. Are synaptic MAGUK proteins involved in chronic pain?. Trends Pharmacol Sci 25 (2004) 397-400
74. Tsui J., and Malenka R.C. Substrate localization creates specificity in calcium/calmodulin-dependent protein kinase II signaling at synapses. J Biol Chem 281 (2006) 13794-13804
75. Ulas J., and Cotman C. Dopaminergic denervation of striatum results in elevated expression of NR2A subunit. Neuroreport 7 (1996) 1789-1793
76. Vila M., Marin C., Ruberg M., Jimenezs A., Raisman-Vozari R., Agid Y., Tolosa E., and Hirsch E.C. Systemic administration of NMDA and AMPA receptor antagonists reverses the neurochemical changes induced by nigrostriatal denervation in basal ganglia. J Neurochem 73 (1999) 344-352
77. Wakabayashi K., Narisawa-Saito M., Iwakura Y., Arai T., Ikeda K., Takahashi H., and Nawa H. Phenotypic down-regulation of glutamate receptor subunit GluR1 in Alzheimer's disease. Neurobiol Aging 20 (1999) 287-295
78. Walsh D.M., Klyubin I., Fadeeva J.V., Cullen W.K., Anwyl R., Wolfe M.S., Rowan M.J., and Selkoe D.J. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416 (2002) 535-539
79. Wang H.W., Pasternak J.F., Kuo H., Ristic H., Lambert M.P., Chromy B., Viola K.L., Klein W.L., Stine W.B., Krafft G.A., and Trommer B.L. Soluble oligomers of beta amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus. Brain Res 924 (2002) 133-140
80. Winblad B., and Poritis N. Memantine in severe dementia: results of the 9M-Best Study (Benefit and Efficacy in Severely Demented Patients During Treatment with Memantine). Int J Geriatr Psychiatry 14 (1999) 135-146
81. Yoshimura Y., Shinkawa T., Taoka M., Kobayashi K., Isobe T., and Yamauchi T. Identification of protein substrates of Ca (2+)/calmodulin dependent protein kinase II in the postsynaptic density by protein sequencing and mass spectrometry. Biochem Biophys Res Commun 290 (2002) 948-954